ExploreWatchlistsPricing
  1. JP-listed companies
  2. Shionogi & Co.,Ltd.
  3. Financials
  4. Marketable securities, non-current

Shionogi & Co.,Ltd. (4507)

Market cap
¥2.86T
P/E ratio
14.6x
Develops, manufactures and sells prescription pharmaceuticals globally, specializing in infectious diseases and central nervous system disorders.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndMarketable securities, non-current (Million JPY)YoY (%)
Mar 31, 2025299,799+2.56%
Mar 31, 2024292,321+18.01%
Mar 31, 2023247,711+2.16%
Mar 31, 2022242,479+11.52%
Mar 31, 2021217,437+7.56%
Mar 31, 2020202,161+33.13%
Mar 31, 2019151,851-2.46%
Mar 31, 2018155,675+14.49%
Mar 31, 2017135,970-7.16%
Mar 31, 2016146,451-7.51%
Mar 31, 2015158,339

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat